HighTower Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

HighTower Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,012	Closed	-$5K	–	3772
2022 Q4	$5K	Hold	21,012	–	–	﹤0.01%	3215
2022 Q3	$8K	Hold	21,012	–	–	﹤0.01%	3036
2022 Q2	$14K	Hold	21,012	–	–	﹤0.01%	3044
2022 Q1	$17K	Hold	21,012	–	–	﹤0.01%	3183
2021 Q4	$24K	Sell	21,012 -200	-0.9%	-$407	﹤0.01%	3092
2021 Q3	$54K	Buy	21,212 +3,212	+18%	+$8.91K	﹤0.01%	2931
2021 Q2	$53K	Hold	18,000	–	–	﹤0.01%	2885
2021 Q1	$63K	Sell	18,000 -35,541	-66%	-$198K	﹤0.01%	2804
2020 Q4	$255K	Buy	53,541 +8,263	+18%	+$42.7K	﹤0.01%	2044
2020 Q3	$219K	Hold	45,278	–	–	﹤0.01%	2033
2020 Q2	$148K	Buy	45,278 +11,463	+34%	+$109K	﹤0.01%	2058
2020 Q1	$173K	Hold	33,815	–	–	﹤0.01%	1829
2019 Q4	$155K	Buy	33,815 +19,000	+128%	+$92.6K	﹤0.01%	2027
2019 Q3	$91K	Hold	14,815	–	–	﹤0.01%	2176
2019 Q2	$90K	Buy	+14,815	New	+$99.9K	﹤0.01%	2172
2018 Q4	–	Sell	-13,882	Closed	-$145K	–	2473
2018 Q3	$145K	Buy	+13,882	New	+$149K	﹤0.01%	2006

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

HighTower Advisors's CEMI Position: Q1 2023 in Review

HighTower Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 21,012 shares — an estimated $5K sold.

HighTower Advisors first reported a position in CEMI in Q3 2018 and held it in 16 quarters. The position peaked at $255K in Q4 2020. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

HighTower Advisors reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
HighTower Advisors sold 21,012 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $5K.
HighTower Advisors first reported a position in Chembio diagnostics, Inc. in Q3 2018 and held it in 16 quarters.
HighTower Advisors's Chembio diagnostics, Inc. position peaked at $255K in Q4 2020.
30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on HighTower Advisors's 13F filing for Q1 2023, filed 12 May 2023.